Patents Assigned to TECTON GROUP, LLC
  • Patent number: 11865127
    Abstract: The present invention provides a composition comprising a mixture of an exogenous ketone body, an exogenous NAD modulator and a methyl donor. Typically, exogenous NAD modulator is an exogenous nicotinamide adenine dinucleotide (NAD) precursor. The present invention also provides a method of using such a composition for treating various clinical conditions, including metabolic disorders and neurocognitive impairments. The compositions of the invention can also be used to improve human performance in various competitive or environmental conditions.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: January 9, 2024
    Assignee: Tecton Group, LLC
    Inventor: Michael A. Schmidt
  • Patent number: 11202790
    Abstract: The present invention provides a composition comprising a mixture of an exogenous ketone body, an exogenous NAD modulator and a methyl donor. Typically, exogenous NAD modulator is an exogenous nicotinamide adenine dinucleotide (NAD) precursor. The present invention also provides a method of using such a composition for treating various clinical conditions, including metabolic disorders and neurocognitive impairments. The compositions of the invention can also be used to improve human performance in various competitive or environmental conditions.
    Type: Grant
    Filed: May 8, 2020
    Date of Patent: December 21, 2021
    Assignee: TECTON GROUP, LLC
    Inventor: Michael A. Schmidt
  • Patent number: 10688115
    Abstract: The present invention provides a composition comprising a mixture of an exogenous ketone body, an exogenous NAD modulator and a methyl donor. Typically, exogenous NAD modulator is an exogenous nicotinamide adenine dinucleotide (NAD) precursor. The present invention also provides a method of using such a composition for treating various clinical conditions, including metabolic disorders and neurocognitive impairments. The compositions of the invention can also be used to improve human performance in various competitive or environmental conditions.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: June 23, 2020
    Assignee: Tecton Group, LLC
    Inventor: Michael A. Schmidt
  • Patent number: 10456411
    Abstract: The present invention provides a composition comprising a mixture of an exogenous ketone body, an exogenous NAD modulator and a methyl donor. Typically, exogenous NAD modulator is an exogenous nicotinamide adenine dinucleotide (NAD) precursor. The present invention also provides a method of using such a composition for treating various clinical conditions, including metabolic disorders and neurocognitive impairments. The compositions of the invention can also be used to improve human performance in various competitive or environmental conditions.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: October 29, 2019
    Assignee: Tecton Group, LLC
    Inventor: Michael A. Schmidt
  • Patent number: 10376528
    Abstract: The present invention provides a composition comprising a mixture of an exogenous ketone body, an exogenous NAD modulator and a methyl donor. Typically, exogenous NAD modulator is an exogenous nicotinamide adenine dinucleotide (NAD) precursor. The present invention also provides a method of using such a composition for treating various clinical conditions, including metabolic disorders and neurocognitive impairments. The compositions of the invention can also be used to improve human performance in various competitive or environmental conditions.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: August 13, 2019
    Assignee: TECTON GROUP, LLC
    Inventor: Michael A. Schmidt